未登录

A

Alan Cheng

Medtronic

H指数:48

被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Assessing Differences in Accuracy Across Implantable Loop Recorders Comparing Apples to Oranges

评估植入式环形记录仪之间准确性的差异——比较不同类型的设备

JACC-Clinical Electrophysiology

IF7.7

2026-07-010

PRE

Pacing-Induced Cardiomyopathy Following Leadless and Transvenous Pacemaker Implantation: A Multicenter Retrospective Study

起搏器诱导的心肌病：经导管和无导线起搏器植入后的多中心回顾性研究

IF2.9

2025-09-020

OAAI

Evaluating Long-Term Oncologic Outcomes of Radiofrequency Ablation for T1a Renal Cell Carcinoma with Minimum 10 Years of Follow-Up

评估射频消融治疗T1a期肾细胞癌的长期肿瘤学结局（随访时间至少10年）

JOURNAL OF ENDOUROLOGY

IF2.8

2025-04-240

PRE

Comparing ambulatory to inpatient percutaneous nephrolithotomy: systematic review and meta-analysis

比较门诊和住院经皮肾镜取石术: 系统回顾和荟萃分析

BJU INTERNATIONAL

IF4.4

2024-12-041

PRE

Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Major Medical Journals

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

IF55

2024-11-051

PRE

Randomized Controlled Trials Assessing Continuous Outcomes for the Use of Platelet-Rich Plasma in Knee Osteoarthritis Are Statistically Fragile: A Systematic Review

评估富血小板血浆在膝关节骨关节炎中应用效果的随机对照试验存在统计脆弱性：一项系统综述

arthroscopy the journal of arthroscopic and related surgery

IF0

2024-10-100

OAAI

Outcomes of patients implanted with an atrioventricular synchronous leadless ventricular pacemaker in the Medicare population

IF5.7

2024-01-019

PRE

Three-year chronic follow-up from the pilot study of a substernal extravascular implantable cardioverter-defibrillator

IF7.4

2023-10-171

OAAI

Trends in implantable cardioverter-defibrillator programming practices and its impact on therapies: Insights from a North American Remote Monitoring Registry 2007-2018

IF5.7

2022-02-016

OA

Predictors of Sudden Cardiac Arrest Among Patients With Post-Myocardial Infarction Ejection Fraction Greater Than 35%

JOURNAL OF THE AMERICAN HEART ASSOCIATION

IF5.3

2021-07-207

OAAI

An attempt to reconcile the contrasting results of analyses on implantable cardioverter-defibrillator shocks during the pandemic

EUROPEAN HEART JOURNAL

IF35.6

2021-07-191

OA

Implantable Cardioverter-Defibrillator Shocks During COVID-19 Outbreak

JOURNAL OF THE AMERICAN HEART ASSOCIATION

IF5.3

2021-06-0111

OAAI

Clinical Presentation, Timing, and Microbiology of CIED Infections An Analysis of the WRAP-IT Trial

JACC-CLINICAL ELECTROPHYSIOLOGY

IF7.7

2021-01-0120

OAAI

Morbidity and mortality in patients precluded for transvenous pacemaker implantation: Experience with a leadless pacemaker

IF5.7

2020-12-0114

PREAI

First-in-Human Chronic Implant Experience of the Substernal Extravascular Implantable Cardioverter-Defibrillator

JACC-CLINICAL ELECTROPHYSIOLOGY

IF7.7

2020-11-0133

OAAI

Bilateral Bundle Branch Area Pacing to Achieve Physiological Conduction System Activation

CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY

IF9.8

2020-08-0124

OAAI

Modeling defibrillation benefit for survival among cardiac resynchronization therapy defibrillator recipients

AMERICAN HEART JOURNAL

IF3.5

2020-04-015

OAAI

Utilization of implantable cardioverter-defibrillators for the prevention of sudden cardiac death in emerging countries: Improve SCA clinical trial

IF5.7

2020-03-0122

OAAI

Additional antitachycardia pacing programming strategies further reduce unnecessary implantable cardioverter-defibrillator shocks

IF5.7

2020-01-014

PREAI

Diurnal, Seasonal, and Monthly Variations in Ventricular Arrhythmias in Patients With Implantable Cardioverter-Defibrillators

JACC-CLINICAL ELECTROPHYSIOLOGY

IF7.7

2019-08-014

PREAI